Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmacia Genotropin (somatropin) will be launched in beginning of 1996.

Executive Summary

PHARMACIA GENOTROPIN HUMAN GROWTH HORMONE LAUNCH SET FOR EARLY 1996 following the Aug. 24 approval of the somatropin product for the long-term treatment of children who have growth failure due to inadequate endogenous growth hormone levels. While two other somatropin products were approved in 1995, Novo Nordisk's Norditropin and Bio-Technology General's Bio-Tropin, Pharmacia's may be the first to market because the company will not face a patent infringement challenge by Genentech. Pharmacia is also planning a new packaging approach for its growth hormone product.

You may also be interested in...



Pharmacia Is First Manufacturer Busted For Receiving Kickbacks From A PBM

Pfizer subsidiary Pharmacia & Upjohn Company Inc. pleaded guilty to violating the Anti-Kickback Act, marking the first settlement by a manufacturer with prosecutors over excessive payments on a distribution contract with a pharmacy benefit manger

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
UsernamePublicRestriction

Register

PS026813

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel